BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35902878)

  • 21. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
    Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generating Homogeneous Brain Organoids from Human iPSCs.
    Chen X; Shi Y
    Methods Mol Biol; 2024; 2794():157-167. PubMed ID: 38630227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of integration free human iPSC line SORMi002-A from neonatal foreskin fibroblasts.
    Shivaraj A; Parveen S
    Stem Cell Res; 2019 Oct; 40():101534. PubMed ID: 31454679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progesterone receptor A-regulated gene expression in mammary organoid cultures.
    Santos SJ; Aupperlee MD; Xie J; Durairaj S; Miksicek R; Conrad SE; Leipprandt JR; Tan YS; Schwartz RC; Haslam SZ
    J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):161-72. PubMed ID: 19383543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
    Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
    Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Mammary Organoid Model to Study Branching Morphogenesis.
    Caruso M; Huang S; Mourao L; Scheele CLGJ
    Front Physiol; 2022; 13():826107. PubMed ID: 35399282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Derivation and characterization of induced pluripotent stem cells from equine fibroblasts.
    Breton A; Sharma R; Diaz AC; Parham AG; Graham A; Neil C; Whitelaw CB; Milne E; Donadeu FX
    Stem Cells Dev; 2013 Feb; 22(4):611-21. PubMed ID: 22897112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
    Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
    Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels.
    Mollica PA; Booth-Creech EN; Reid JA; Zamponi M; Sullivan SM; Palmer XL; Sachs PC; Bruno RD
    Acta Biomater; 2019 Sep; 95():201-213. PubMed ID: 31233891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Cytomegalovirus Compromises Development of Cerebral Organoids.
    Brown RM; Rana PSJB; Jaeger HK; O'Dowd JM; Balemba OB; Fortunato EA
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of a mammary stromal cell line into a mammary fat pad: development of the site-specific in vivo analysis system for mammary stromal cells.
    Nakatani H; Aoki N; Nadano D; Matsuda T
    Biosci Biotechnol Biochem; 2011; 75(3):550-5. PubMed ID: 21389616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1 mutation influences progesterone response in human benign mammary organoids.
    Davaadelger B; Choi MR; Singhal H; Clare SE; Khan SA; Kim JJ
    Breast Cancer Res; 2019 Nov; 21(1):124. PubMed ID: 31771627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts.
    Liu J; Ashton MP; Sumer H; O'Bryan MK; Brodnicki TC; Verma PJ
    Diabetes; 2011 May; 60(5):1393-8. PubMed ID: 21464439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation of human breast epithelia to mammary-gland-free fat-pads of athymic nude mice: influence of mammotrophic hormones on growth of breast epithelia.
    Sheffield LG; Welsch CW
    Int J Cancer; 1988 May; 41(5):713-9. PubMed ID: 3366492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding the evo-devo toolkit: generation of 3D mammary tissue from diverse mammals.
    Kim HY; Sinha I; Sears KE; Kuperwasser C; Rauner G
    Development; 2024 Jan; 151(2):. PubMed ID: 38276965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatiotemporal modulation of growth factors directs the generation of multilineage mouse embryonic stem cell-derived mammary organoids.
    Sahu S; Sahoo S; Sullivan T; O'Sullivan TN; Turan S; Albaugh ME; Burkett S; Tran B; Salomon DS; Kozlov SV; Koehler KR; Jolly MK; Sharan SK
    Dev Cell; 2024 Jan; 59(2):175-186.e8. PubMed ID: 38159568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.